Kesimpta (MS)

Indicated For

Relapsing forms of multiple sclerosis (RMS), Clinically isolated syndrome, Relapsing-remitting disease, Active secondary progressive disease

About This Medication

# Getting Kesimpta (Ofatumumab) at No Cost Through the Novartis Patient Assistance Foundation (NPAF) ## Who Qualifies for the Novartis Patient Assistance Foundation (NPAF)? If you have been prescribed Kesimpta for multiple sclerosis but cannot afford it, you may be able to get it at no cost through the **Novartis Patient Assistance Foundation (NPAF)**. This program provides free medication to patients who meet financial and insurance requirements. For a single-person household, your annual income must be at or below **$75,300** to qualify. To be eligible, you must be uninsured, underinsured, or enrolled in Medicare Part D and lack adequate coverage for Kesimpta. If you meet these criteria, the NPAF may ship your medication directly to your home at no charge. --- ## About Kesimpta (MS) (Ofatumumab) Kesimpta (ofatumumab) is a prescription medication approved by the FDA to treat **relapsing forms of multiple sclerosis (RMS)** in adults. This includes clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. It belongs to a drug class called CD20-directed cytolytic antibodies and is administered as a self-injection under the skin. Without insurance or financial assistance, Kesimpta can cost tens of thousands of dollars per year, placing it out of reach for many patients. The NPAF program exists specifically to help patients access this medication when cost is a barrier. --- ## Income Eligibility: Full Breakdown The NPAF uses income thresholds set at **500% of the Federal Poverty Level (FPL)** for 2025. The limits by household size are: | Household Size | Max Annual Income | |---|---| | 1 person | $75,300 | | 2 persons | $102,200 | | 3 persons | $129,100 | | 4 persons | $156,000 | Your income is typically verified using your **most recent federal tax return, W-2, 1099 forms, or three months of recent pay stubs**. If your income sources are irregular — for example, if you are self-employed or have seasonal work — multiple documents may be needed to give a complete picture. If your income is slightly above these limits, do not assume you are automatically disqualified. NPAF has the ability to review individual cases for **financial hardship**, meaning extraordinary medical expenses or other factors may be considered. It is worth applying or calling **(800) 277-2254** to discuss your situation before giving up. Households larger than four people may also contact NPAF directly, as the income scale continues beyond the four-person threshold shown here. --- ## Insurance Requirements Explained Your insurance status plays a key role in whether you qualify. Here is how each situation is handled: - **If you are uninsured:** You are a strong candidate for the NPAF program. Patients with no insurance coverage are among the primary groups this program is designed to serve, provided you also meet the income requirements. - **If you have Medicare Part D:** You may still qualify. Unlike many manufacturer assistance programs that exclude Medicare beneficiaries entirely, NPAF accepts Medicare Part D patients who meet financial criteria and do not have adequate coverage for Kesimpta through their plan. - **If you have private insurance that covers less than 50% of costs:** You may qualify as an "underinsured" patient. If your out-of-pocket costs remain unaffordable after your insurance pays its portion, NPAF may still be able to help. Each case is reviewed individually. - **If you have Medicaid:** Patients with full Medicaid coverage that includes Kesimpta are generally not eligible, since the program is intended for those who lack coverage for the medication. If your Medicaid plan does not cover Kesimpta, contact NPAF to discuss your options. --- ## Step-by-Step: How to Apply 1. **Gather your documents before you start.** You will need: proof of income (tax return, W-2, 1099, or pay stubs from the last three months), a valid prescription for Kesimpta, and a signed patient authorization form. 2. **Choose your application method.** You can apply online, by phone, or by fax. - **Online:** Visit [https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance/novartis-patient-assistance-foundation-inc](https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance/novartis-patient-assistance-foundation-inc) to access the application portal. - **By phone:** Call **(800) 277-2254** to speak with a program representative who can guide you through the process. - **By fax:** Submit completed forms to **(866) 817-1528**. 3. **Complete the prescriber section.** Your doctor or their office staff must fill out and sign the prescriber portion of the application. Many offices are familiar with this process — ask your neurologist's office to assist you. 4. **Sign the patient authorization form.** This gives NPAF permission to verify your information and process your request. Without this signature, your application cannot move forward. 5. **Submit everything together.** Incomplete applications cause delays. Double-check that all sections are filled in and all documents are included before submitting. 6. **Wait for a decision.** NPAF typically completes its review within **two business days**. You or your prescriber's office will be notified of the outcome. --- ## What to Expect: Timeline and Delivery Once your application is approved, NPAF typically processes the review within **two business days**. After approval, your Kesimpta will be **shipped directly to your home** — you do not need to pick it up at a pharmacy or your doctor's office. Make sure your mailing address on the application is current and that someone will be available to receive temperature-sensitive medication if required. **Reauthorization is required once per year.** Before your approval period ends, you will need to resubmit income documentation and a current prescription to continue receiving free medication. Watch for renewal reminders and plan ahead so you do not experience a gap in your supply. --- ## Alternatives If You Don't Qualify If you do not meet the NPAF's requirements, there are still options worth exploring: 1. **Biosimilars:** There are currently **no FDA-approved biosimilar alternatives** to Kesimpta (ofatumumab). This may change in the future, but at this time, no lower-cost biosimilar version is available. 2. **Manufacturer savings card:** If you have **commercial or private insurance**, Novartis offers a co-pay savings program for Kesimpta. This can significantly reduce your out-of-pocket costs. Visit [https://www.kesimpta.com/co-pay-savings-support](https://www.kesimpta.com/co-pay-savings-support) to learn more and enroll. 3. **State Pharmaceutical Assistance Programs (SPAPs):** Many states operate their own drug assistance programs, particularly for older adults or people with disabilities. Search your state's health department website or ask your doctor's office for a referral. 4. **NeedyMeds.org:** This free, independent database at [www.needymeds.org](https://www.needymeds.org) lists hundreds of patient assistance programs, co-pay cards, and disease-specific funds. It is a useful starting point if you need to explore multiple avenues. --- > *This guide is for informational purposes only and does not constitute medical or legal advice. Eligibility determinations are made solely by Novartis. Program terms may change — verify current requirements at [https://www.kesimpta.com/support/financial-support](https://www.kesimpta.com/support/financial-support) before applying.* ---

Program information last verified: February 27, 2026